|
PARG expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.14330000000351E-05 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.555400E-04 |
| Normal-vs-Stage2 |
3.537100E-03 |
| Normal-vs-Stage3 |
2.05549999999777E-05 |
| Normal-vs-Stage4 |
2.21699999999325E-05 |
| Stage1-vs-Stage2 |
7.772600E-01 |
| Stage1-vs-Stage3 |
1.354160E-01 |
| Stage1-vs-Stage4 |
1.263400E-01 |
| Stage2-vs-Stage3 |
4.452800E-01 |
| Stage2-vs-Stage4 |
3.067200E-01 |
| Stage3-vs-Stage4 |
7.067000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.57129999999973E-05 |
| Normal-vs-AfricanAmerican |
9.312200E-02 |
| Normal-vs-Asian |
4.043600E-03 |
| Caucasian-vs-AfricanAmerican |
2.830800E-01 |
| Caucasian-vs-Asian |
8.322000E-01 |
| AfricanAmerican-vs-Asian |
3.941400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.82767999999944E-05 |
| Normal-vs-Female |
1.823030E-04 |
| Male-vs-Female |
1.612580E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.257500E-03 |
| Normal-vs-Age(41-60Yrs) |
3.9544000000058E-05 |
| Normal-vs-Age(61-80Yrs) |
7.91220000000425E-05 |
| Normal-vs-Age(81-100Yrs) |
1.010420E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.586350E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.637000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.125200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.204400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.678400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.064800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.272800E-01 |
| Classical-VS-Follicular |
1.459830E-03 |
| Classical-VS-Other |
1.323210E-01 |
| Classical-VS-Normal |
1.776240E-03 |
| Tall-VS-Follicular |
2.009600E-01 |
| Tall-VS-Other |
2.690400E-01 |
| Tall-VS-Normal |
8.344300E-03 |
| Follicular-VS-Other |
6.868600E-01 |
| Follicular-VS-Normal |
1.81359999995578E-06 |
| Other-VS-Normal |
9.917100E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.77510000000303E-05 |
| Normal-vs-N1 |
1.413750E-04 |
| N0-vs-N1 |
3.988800E-01 |
|
|
